Friday 9 June 2023

A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus

A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus submitted by /u/DoremusJessup
[link] [comments]


from Health https://ift.tt/PQRVSNy
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)